All AbMole products are for research use only, cannot be used for human consumption.
YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.
| Cell Experiment | |
|---|---|
| Cell lines | |
| Preparation method | |
| Concentrations | |
| Incubation time | |
| Animal Experiment | |
|---|---|
| Animal models | Rats and rhesus macaques |
| Formulation | Converted to its hydrochloride salt by treatment with 4 M HCl in dioxane. |
| Dosages | 14 mg/kg (rats), 13.4 mg/kg (rhesus macaques) |
| Administration | i.v |
| Molecular Weight | 317.43 |
| Formula | C18H27N3O2 |
| CAS Number | 144217-65-2 |
| Form | Solid |
| Solubility (25°C) | DMSO |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Takaaki Mizuguchi, et al. A minimally cytotoxic CD4 mimic as an HIV entry inhibitor
[2] Chie Hashimoto, et al. A CD4 mimic as an HIV entry inhibitor: pharmacokinetics
| Related HIV Protease Products |
|---|
| Ritonavir-13c,d3
Ritonavir-13c,d3 |
| Arg-Val-(Nle-p-nitro)-Phe-Glu-Ala-Nle-NH2
Arg-Val-(Nle-p-nitro)-Phe-Glu-Ala-Nle-NH2 is a fluorogenic substrate of HIV-1 protease. |
| Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 is a substrato peptídico of HIV-1 protease. |
| HIV-1, HIV-2 Protease Substrate
HIV-1, HIV-2 Protease Substrate is the substrate of HIV-1, HIV-2 protease. |
| HIV Protease Substrate IV
HIV Protease Substrate IV is a substrate of HIV protease. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
